Open RFP

TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation RFP

Description: Protein-based rare earth recovery via condensation from scientists at laboratory offers a cleaner, flexible way to capture and concentrate rare earth elements from complex liquid mixtures by using a bio-inspired protein system that gathers target metals into separable clusters.

Buyer: Triad National Security (Los Alamos) (Contractor)
Federal · NM, US
Released: Jun 22, 2026
Closes: Dec 22, 2026(55 days left)

Files

Original attachments and procurement documents tied to this bid.

Federal RFP files are for Starbridge customers only.

You can request RFP files from all other buyer types for free on this site.

Key Contacts on this RFP

Decision makers connected to this RFP from Triad National Security (Los Alamos) (Contractor).

Lisa LloydChief Financial Officer

*******@************

+1 (***) ***-****

Elaine SchuckChief Information Security Officer

*******@************

+1 (***) ***-****

Rachel Byars SchroederDirector of Internal Audit & Ethics

*******@************

+1 (***) ***-****

Thomas MasonLaboratory Director

*******@************

+1 (***) ***-****

Similar active RFPs

Adjacent opportunities open for bidding right now.

Em-Los Alamos
FederalNM
Posted
Jun 22, 2026
Closes
Dec 23, 2026
TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation
TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation, developed by scientists at Los Alamos National Laboratory, offers a bio-based method to capture and concentrate rare earth elements from complex liquid mixtures using engineered Lanmodulin (EP-LanM) proteins that self-assemble into recoverable condensates. The technology is at TRL 3 with a U.S. Patent pending (LA-UR-26-25158) and supports applications in critical minerals recovery, mining, e-waste recycling, environmental remediation, and biomanufacturing. This is a Special Notice, not a procurement or grant — LANL is seeking industry partners to license and commercialize the technology.
Idaho Operations Office
FederalID
Posted
Sep 15, 2025
Closes
Nov 15, 2026
Technology Licensing Opportunity: Room-Temperature Electrochemical Metallization of Rare Earth Elements
Provide technology licensing opportunity: room-temperature electrochemical metallization of rare earth elements.
Triad National Security (Los Alamos) (Contractor)
FederalNM
Posted
Jun 5, 2026
Closes
Dec 5, 2026
TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro RFP
SurfGraphPro, an AI tool, transforms complex protein structures into an easy-to-analyze format that helps researchers quickly identify binding sites, predict molecular interactions and understand protein behavior with greater speed and scalability than traditional approaches. By combining 3D surface graph representations with advanced machine learning, this technology from Los Alamos National Laboratory reduces the computational burden of protein analysis while preserving the structural detail needed for high-value applications in drug discovery, antibody design, pathogen detection and custom protein engineering.
Triad National Security (Los Alamos) (Contractor)
FederalNM
Posted
Jun 17, 2026
Closes
Dec 17, 2026
TECHNOLOGY LICENSING OPPORTUNITY: NanoFET RFP
NanoFiber Engineered Therapeutics Platform (NanoFET) from Laboratory offers pharmaceutical and biodefense organizations a modular, adaptable scaffold for building next-generation immunotherapies. By merging self-assembling peptide nanofibers with interchangeable nanobody and peptide components, the platform enables rapid development of targeted treatments that bridge disease agents directly to the patient’s own immune cells.

See your top accountsScan your site in seconds. Starbridge identifies your ICP and surfaces emerging opportunities from board meetings, job changes, new grants, contract expirations, RFPs, and more.

See your top 10 accounts

Similar active RFPs

Adjacent opportunities open for bidding right now.

Em-Los Alamos

FederalNM

Posted

Jun 22, 2026

Closes

Dec 23, 2026

TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation

TECHNOLOGY LICENSING OPPORTUNITY: Protein-Based Rare Earth Recovery via Condensation, developed by scientists at Los Alamos National Laboratory, offers a bio-based method to capture and concentrate rare earth elements from complex liquid mixtures using engineered Lanmodulin (EP-LanM) proteins that self-assemble into recoverable condensates. The technology is at TRL 3 with a U.S. Patent pending (LA-UR-26-25158) and supports applications in critical minerals recovery, mining, e-waste recycling, environmental remediation, and biomanufacturing. This is a Special Notice, not a procurement or grant — LANL is seeking industry partners to license and commercialize the technology.

Idaho Operations Office

FederalID

Posted

Sep 15, 2025

Closes

Nov 15, 2026

Technology Licensing Opportunity: Room-Temperature Electrochemical Metallization of Rare Earth Elements

Provide technology licensing opportunity: room-temperature electrochemical metallization of rare earth elements.

Triad National Security (Los Alamos) (Contractor)

FederalNM

Posted

Jun 5, 2026

Closes

Dec 5, 2026

TECHNOLOGY LICENSING OPPORTUNITY: SurfGraphPro RFP

SurfGraphPro, an AI tool, transforms complex protein structures into an easy-to-analyze format that helps researchers quickly identify binding sites, predict molecular interactions and understand protein behavior with greater speed and scalability than traditional approaches. By combining 3D surface graph representations with advanced machine learning, this technology from Los Alamos National Laboratory reduces the computational burden of protein analysis while preserving the structural detail needed for high-value applications in drug discovery, antibody design, pathogen detection and custom protein engineering.

Triad National Security (Los Alamos) (Contractor)

FederalNM

Posted

Jun 17, 2026

Closes

Dec 17, 2026

TECHNOLOGY LICENSING OPPORTUNITY: NanoFET RFP

NanoFiber Engineered Therapeutics Platform (NanoFET) from Laboratory offers pharmaceutical and biodefense organizations a modular, adaptable scaffold for building next-generation immunotherapies. By merging self-assembling peptide nanofibers with interchangeable nanobody and peptide components, the platform enables rapid development of targeted treatments that bridge disease agents directly to the patient’s own immune cells.